Selected 2003 Venture Capital Transactions as Company Counsel
- 1.1.2004
In 2003 we continue to represent more venture-backed companies in the eastern U.S. than any other law firm in the country. Representative transactions to date include the following:
- Acopia Networks — $30 million
- Alnylam Pharmaceuticals — $24.6 million
- Ammasso — $10 million
- Angiolink — $13.6 million
- Ardais — $13.4 million
- Axiowave Networks — $45 million
- BioVex — $28 million
- Blue Agave Software — $6 million
- Compound Therapeutics — $12 million
- Critical Therapeutics — $56 million
- Deploy Solutions — $21 million
- EM4 — $8 million
- Endius — $26.5 million
- Evident Software — $6.8 million
- Eyetech Pharmaceuticals — $25 million
- Eziba — $3.8 million
- GenPath Pharmaceuticals — $42.7 million
- Idenix Pharmaceuticals — $255 million
- Incipient — $25 million
- IntelliVid — $5.5 million
- Jedai Broadband Networks — $10 million
- Linguagem — $10.2 million
- LiveVault — $10 million
- Momenta Pharmaceuticals — $19 million
- Nantero — $10.5 million
- Neothermia — $13.1 million
- Netezza — $20 million
- Netilla Networks — $5 million
- Optiant — $10.5 million
- Performaworks — $13 million
- Princeton eCom — $5 million
- Quallaby — $5 million
- Quantum Bridge Communications — $20 million
- Starent Networks — $23 million
- Storability — $7 million
- Tazz Networks — $10.5 million
- VistaPrint — $30 million
- Water Cove Networks — $20 million
